Provided by Tiger Fintech (Singapore) Pte. Ltd.

Passage Bio, Inc.

5.74
-0.6800-10.59%
Post-market: 5.740.00000.00%19:28 EDT
Volume:48.93K
Turnover:285.64K
Market Cap:17.91M
PE:-0.28
High:6.35
Open:6.29
Low:5.60
Close:6.42
Loading ...

Passage Bio Regains Nasdaq Compliance with Stock Price

TIPRANKS
·
30 Jul

Major Shareholder Makes Bold Move with Passage Bio Stock Purchase!

TIPRANKS
·
25 Jul

Weston Nichols, a Beneficial Owner, Reports Acquisition of Passage Bio Inc. Common Shares

Reuters
·
25 Jul

Passage Bio Announces 1-for-20 Reverse Stock Split Effective July 14, 2025

Reuters
·
14 Jul

Passage Bio trading halted, news pending

TIPRANKS
·
12 Jul

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, AbbVie, McDonald's

Reuters
·
11 Jul

BUZZ-Passage Bio falls after reverse stock split

Reuters
·
10 Jul

BRIEF-Passage Bio Announces 1-For-20 Reverse Stock Split

Reuters
·
10 Jul

Passage Bio Inc. Announces 1-for-20 Reverse Stock Split to Regain Nasdaq Compliance

Reuters
·
10 Jul

Optimistic Buy Rating for Passage Bio’s PBFT02: Promising Efficacy and Managed Safety Concerns

TIPRANKS
·
28 Jun

Major Shareholder Orbimed Advisors Sells Huge Chunk of Passage Bio Stock!

TIPRANKS
·
27 Jun

OrbiMed Advisors LLC Reports Disposal of Common Shares of Passage Bio Inc

Reuters
·
27 Jun

Passage Bio Is Maintained at Buy by Chardan Capital

Dow Jones
·
24 Jun

Passage Bio’s Promising Clinical Trial Results and Strategic Adjustments Justify Buy Rating

TIPRANKS
·
24 Jun

Passage Bio (PASG) Receives a Buy from Chardan Capital

TIPRANKS
·
24 Jun

Passage Bio Releases Promising Interim Data for PBFT02

TIPRANKS
·
24 Jun

BRIEF-Passage Bio Reports Updated Interim Data From Uplift-D Study

Reuters
·
23 Jun

Passage Bio Announces Updated Interim Data and Program Advancements for PBFT02 in Frontotemporal Dementia Trial

Reuters
·
23 Jun

Passage Bio Adopts Key Proposals at Annual Meeting

TIPRANKS
·
31 May

Passage Bio Inc. Conducted Annual Stockholders Meeting

Reuters
·
31 May